Visit COVID-19 resources

[Skip to Content]

Clinical real-world results of switching treatment from ranibizumab to aflibercept in patients with diabetic macular oedema – (Eye Journal AOP)

16 June 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login